Home
›
Videos
›
Dermbits
›
Endpoints Extended To 57 Days
How do you advise scheduling follow-up visits for patients on tirbanibulin, knowing pivotal trial endpoints extended to 57 days?
Featuring:
VP
Vishal Patel, MD, FACMS, FAAD
Faculty
Updated:
Aug 18, 2026
Actinic Keratosis
CME & Education
About Us
Loading profile...
Conditions & Treatments
Learn from the Experts
Support Your Practice
Conferences & Highlights
CME Activities
Educational Resources
Community Resources
Our Expert Network